ID: ALA4129213

Max Phase: Preclinical

Molecular Formula: C7H11ClN4S

Molecular Weight: 182.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.N=C(N)Nc1nc2c(s1)CCC2

Standard InChI:  InChI=1S/C7H10N4S.ClH/c8-6(9)11-7-10-4-2-1-3-5(4)12-7;/h1-3H2,(H4,8,9,10,11);1H

Standard InChI Key:  OXBUCOIXHFIUPC-UHFFFAOYSA-N

Associated Targets(Human)

Adrenergic receptor alpha-2 812 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 182.25Molecular Weight (Monoisotopic): 182.0626AlogP: 0.94#Rotatable Bonds: 1
Polar Surface Area: 74.79Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.41CX LogP: 1.30CX LogD: 0.27
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.45Np Likeness Score: -2.26

References

1. Flood A, Trujillo C, Sanchez-Sanz G, Kelly B, Muguruza C, Callado LF, Rozas I..  (2017)  Thiophene/thiazole-benzene replacement on guanidine derivatives targeting α2-Adrenoceptors.,  138  [PMID:28644987] [10.1016/j.ejmech.2017.06.008]

Source